K-numberK252045
Device nameIon Endoluminal System (IF1000)
ApplicantIntuitive Surgical, Inc.
Product codeEOQ
Device classClass II
Decision dateSep 23, 2025
DecisionSubstantially Equivalent
Regulation874.4680
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Ion Endoluminal System (Model IF1000) is a robotic-assisted bronchoscopy platform that helps physicians navigate a catheter and endoscopic tools through the pulmonary tract using real-time visualization of the tracheobronchial tree. It supports diagnostic and therapeutic procedures, including fiducial marker placement, and is not intended for pediatric use.

Technological characteristics

The subject device modifications include: (1) System Software updated to support Tomosynthesis integration, optimize Cone Beam CT workflow, and improve Navigation View; (2) PlanPoint Software modified for Airway Tree Troubleshooting; (3) new Tomosynthesis Board accessory added. All other hardware, instrumentation, and operating principles (leader-follower servomechanism, visualization via light delivery and video, tip deflection navigation) remain identical to the predicate device (K242070).

Test standards cited

Not stated in this summary. The document references FDA Guidance on device software content (June 14, 2023) and cybersecurity requirements under section 524B(b) of the FD&C Act but does not cite specific consensus standards (ISO, IEC, ASTM) for testing.

Substantial equivalence argument

Substantial equivalence is established because the subject device shares identical intended use, indications for use, operating principles, and regulatory classification (Class II, 21 CFR 874.4680) with the predicate (K242070). The modifications (software enhancements and a new accessory board) do not affect critical user tasks, do not raise different safety or effectiveness questions, and are supported by software verification/validation testing, performance testing of the new board, animal testing, and regression testing confirming unmodified functions remain unchanged. The Tomosynthesis capability is established as substantially equivalent by reference to similar technology (Galaxy System, K223144) previously cleared by FDA.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →